IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $386,000 | +29.5% | 9,445 | +1.0% | 0.09% | +22.9% |
| Q1 2020 | $298,000 | +36.1% | 9,350 | -9.7% | 0.07% | +70.7% |
| Q4 2019 | $219,000 | +23.0% | 10,350 | 0.0% | 0.04% | +17.1% |
| Q3 2019 | $178,000 | +12.7% | 10,350 | 0.0% | 0.04% | +12.9% |
| Q2 2019 | $158,000 | -22.9% | 10,350 | -24.6% | 0.03% | -22.5% |
| Q1 2019 | $205,000 | +4.6% | 13,725 | 0.0% | 0.04% | -7.0% |
| Q4 2018 | $196,000 | -31.5% | 13,725 | 0.0% | 0.04% | -14.0% |
| Q3 2018 | $286,000 | -14.1% | 13,725 | -2.6% | 0.05% | -15.3% |
| Q2 2018 | $333,000 | +3600.0% | 14,086 | +2287.5% | 0.06% | +2850.0% |
| Q1 2018 | $9,000 | -96.5% | 590 | -96.2% | 0.00% | -95.7% |
| Q4 2017 | $254,000 | +20.4% | 15,725 | +4.0% | 0.05% | +14.6% |
| Q3 2017 | $211,000 | +57.5% | 15,125 | 0.0% | 0.04% | +46.4% |
| Q2 2017 | $134,000 | -8.8% | 15,125 | -33.6% | 0.03% | -12.5% |
| Q1 2017 | $147,000 | +34.9% | 22,775 | -23.5% | 0.03% | +23.1% |
| Q4 2016 | $109,000 | +12.4% | 29,775 | 0.0% | 0.03% | +13.0% |
| Q3 2016 | $97,000 | +15.5% | 29,775 | -17.9% | 0.02% | +21.1% |
| Q2 2016 | $84,000 | -14.3% | 36,275 | -7.6% | 0.02% | -9.5% |
| Q1 2016 | $98,000 | -19.0% | 39,275 | 0.0% | 0.02% | -16.0% |
| Q4 2015 | $121,000 | +57.1% | 39,275 | -12.1% | 0.02% | +47.1% |
| Q3 2015 | $77,000 | -57.5% | 44,675 | 0.0% | 0.02% | -59.5% |
| Q2 2015 | $181,000 | – | 44,675 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |